Legal Opinion
In Re Merck & Co., Inc
Court of Appeals for the Federal Circuit
Decided September 8, 1986No. 85-2740PublishedCited by 69 opinions
1Opinion of the Court
DAVIS, Circuit Judge.
This is an appeal from a final decision of the United States Patent and Trademark Office (PTO) Board of Patent Appeals and Interferences (Board), sustaining the rejection of claims 1 through 3 in the reexamination application1 of U.S. Patent No. 3,428,-735 2 (the ’735 patent) as unpatentable under 35 U.S.C. § 103. We affirm.
I. BACKGROUND
A. The Invention
The invention is directed to a method of treating human mental disorders; the method involves treating depression in humans by the oral administration of 5 — (3—di-methylaminopropylidene)dibenzo[a, d][l, 4] cycloheptadiene…
2Cases cited14 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- In Re Paolo LongiCourt of Appeals for the Federal Circuit · 1985
- In Re Francis J.A.M.C. De Blauwe and Frank K.A. SelleslagsCourt of Appeals for the Federal Circuit · 1984
- In Re Leslie N. Wilder, James C. Whitney and Gary G. Matison, and Lanier Business Products, IntervenorCourt of Appeals for the Federal Circuit · 1984
- Stock Pot Restaurant, Inc. v. Stockpot, Inc.Court of Appeals for the Federal Circuit · 1984
9 more not listed; retrieve them via the Exa API.
3Cited by69 opinions
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- Pharmasterm Therapeutics, Inc. v. Viacell, Inc.Court of Appeals for the Federal Circuit · 2007
- In Re Patrick H. O'farrell, Barry A. Polisky and David H. GelfandCourt of Appeals for the Federal Circuit · 1988
- In Re Huai-Hung KaoCourt of Appeals for the Federal Circuit · 2011
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2014
64 more not listed; retrieve them via the Exa API.